PolyNovo |
Market Cap (3-Oct) $621,757,760 (311th) |
Close (30-Jun) $1.55 |
Volume (30-Jun) 1,225,647 |
Shortsold (28-Sep) 50,391,477 (7.29%) (34th) |
|
52w High $1.56 |
52w Low $0.81 |
P/E 97.09 |
EPS 0.01 |
[ARTICLE] Regal’s Phil King was right on Polynovo ... eventually
A news article has been posted about PolyNovo on the AFR. The article was published around , on 17 November 2021 at 6:13pm.
Still, given we did highlight the fact that Polynovo had soared to new heights shortly after being named as Phil King ’s top short idea at the 2019 Sohn Hearts & Minds conference, suppose we can do Regal Funds Management the courtesy of noting the hedge fund has enjoyed some vindication of late.
Read ArticlePNV was $1.51 at the close of trade on 17 November 2021
| Recent Articles about ASX:PNV | |
|---|---|
| 23-Sep | Cadence Capital Limited ANNUAL REPORT 2026 - AFR
company-announcements.afr.com |
| 22-Sep | ASX Announcement Australian Clinical Labs Limited Tuesday ... - AFR
company-announcements.afr.com |
| 22-Sep | Australian Clinical Labs Limited - 2026 Annual General Meeting - AFR
company-announcements.afr.com |
| 17-Sep | PolyNovo Appoints Dean Phizacklea and Andrew Price as Non ...
company-announcements.afr.com |
| 16-Sep | CADENCE OPPORTUNITIES FUND LIMITED - AFR
company-announcements.afr.com |
| 16-Sep | PolyNovo Limited (ASX: PNV) | For the year ended 30 June 2026
company-announcements.afr.com |
| 22-Aug | 605 Page 1 of 3 - AFR
company-announcements.afr.com |
| 20-Jun | 604 Page 1 of 4 Form 604 Corporations Act 2001 Section 671B ...
company-announcements.afr.com |
| 20-Jun | J.P. MORGAN SECURITIES AUSTRALIA LIMITED JPMORGAN ...
company-announcements.afr.com |
| 12-Jun | PolyNovo U.S. Pivotal Trial – Clinical Study Report Finalised & PMA ...
company-announcements.afr.com |
| Tracked |
Find all articles about PolyNovo, including others on the AFR, on the media page.
You must be logged in to post a reply.